Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.
Authors
Parker, CatrionaWaters, R
Leighton, Carly
Hancock, J
Sutton, R
Moorman, A
Ancliff, P
Morgan, M
Masurekar, Ashish
Goulden, N
Green, N
Révész, T
Darbyshire, P
Love, S
Saha, Vaskar
Affiliation
Cancer Research UK Children's Cancer Group, School of Cancer and Enabling Sciences, University of Manchester, Manchester Academic Health Science Centre, Central Manchester University Hospitals Foundation Trust, Manchester, UK.Issue Date
2010-12-11
Metadata
Show full item recordAbstract
Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who relapse has remained static. We investigated the outcome of children with acute lymphoblastic leukaemia who relapsed on present therapeutic regimens.Citation
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. 2010, 376 (9757):2009-17 LancetJournal
LancetDOI
10.1016/S0140-6736(10)62002-8PubMed ID
21131038Type
ArticleLanguage
enISSN
1474-547Xae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(10)62002-8